11/01/2025 19:32:50
12/19/2022 17:00:00
12/19/2022 18:00:00
Participate in this live event
Register with your My PCR account, add it to your calendar and receive automatic reminders.
Please log into your MyPCR account before proceeding
Coordinators:
Speakers
Objectives:
Join this webinar if you want to:
- Get familiar with the diagnosis and consequences of tricuspid valve dysfunction following right ventricle lead implantation
- Learn how to prevent and manage patients with CIED-induced tricuspid regurgitation
- Learn about surgical and interventional options in patients with right ventricle lead and tricuspid regurgitation
Upcoming webinars in this series
Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease
This webinar is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity.
With C. Leclercq, F. Maisano, M. Andreas, T. de Potter, E. Marijon and N. Wunderlich
Thank you for watching the webinar
To download your certificate of attendance and get your CME credits, please complete the quick satisfaction survey now!
Access hereCoordinators:
Speakers
Objectives:
Watch the replay of this webinar if you want to:
- Get familiar with the diagnosis and consequences of tricuspid valve dysfunction following right ventricle lead implantation
- Learn how to prevent and manage patients with CIED-induced tricuspid regurgitation
- Learn about surgical and interventional options in patients with right ventricle lead and tricuspid regurgitation
Upcoming webinars in this series
Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease